These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 21796625

  • 1. Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics.
    Tang SN, Fu J, Nall D, Rodova M, Shankar S, Srivastava RK.
    Int J Cancer; 2012 Jul 01; 131(1):30-40. PubMed ID: 21796625
    [Abstract] [Full Text] [Related]

  • 2. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway.
    Ma Y, Yu W, Shrivastava A, Alemi F, Lankachandra K, Srivastava RK, Shankar S.
    Carcinogenesis; 2017 Oct 01; 38(10):1047-1056. PubMed ID: 28968696
    [Abstract] [Full Text] [Related]

  • 3. Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway.
    Li SH, Fu J, Watkins DN, Srivastava RK, Shankar S.
    Mol Cell Biochem; 2013 Jan 01; 373(1-2):217-27. PubMed ID: 23129257
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
    Ma Y, Yu W, Shrivastava A, Srivastava RK, Shankar S.
    J Cell Mol Med; 2019 Apr 01; 23(4):2719-2730. PubMed ID: 30712329
    [Abstract] [Full Text] [Related]

  • 5. GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft.
    Fu J, Rodova M, Roy SK, Sharma J, Singh KP, Srivastava RK, Shankar S.
    Cancer Lett; 2013 Mar 01; 330(1):22-32. PubMed ID: 23200667
    [Abstract] [Full Text] [Related]

  • 6. Sonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewal.
    Rodova M, Fu J, Watkins DN, Srivastava RK, Shankar S.
    PLoS One; 2012 Mar 01; 7(9):e46083. PubMed ID: 23029396
    [Abstract] [Full Text] [Related]

  • 7. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth.
    Sharma N, Nanta R, Sharma J, Gunewardena S, Singh KP, Shankar S, Srivastava RK.
    Oncotarget; 2015 Oct 13; 6(31):32039-60. PubMed ID: 26451606
    [Abstract] [Full Text] [Related]

  • 8. Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells.
    Srivastava RK, Tang SN, Zhu W, Meeker D, Shankar S.
    Front Biosci (Elite Ed); 2011 Jan 01; 3(2):515-28. PubMed ID: 21196331
    [Abstract] [Full Text] [Related]

  • 9. Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.
    Shankar S, Nall D, Tang SN, Meeker D, Passarini J, Sharma J, Srivastava RK.
    PLoS One; 2011 Jan 31; 6(1):e16530. PubMed ID: 21304978
    [Abstract] [Full Text] [Related]

  • 10. NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.
    Fu J, Rodova M, Nanta R, Meeker D, Van Veldhuizen PJ, Srivastava RK, Shankar S.
    Neuro Oncol; 2013 Jun 31; 15(6):691-706. PubMed ID: 23482671
    [Abstract] [Full Text] [Related]

  • 11. The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.
    Tang SN, Singh C, Nall D, Meeker D, Shankar S, Srivastava RK.
    J Mol Signal; 2010 Aug 18; 5():14. PubMed ID: 20718984
    [Abstract] [Full Text] [Related]

  • 12. Anthothecol-encapsulated PLGA nanoparticles inhibit pancreatic cancer stem cell growth by modulating sonic hedgehog pathway.
    Verma RK, Yu W, Singh SP, Shankar S, Srivastava RK.
    Nanomedicine; 2015 Nov 18; 11(8):2061-70. PubMed ID: 26199979
    [Abstract] [Full Text] [Related]

  • 13. α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice.
    Verma RK, Yu W, Shrivastava A, Shankar S, Srivastava RK.
    Sci Rep; 2016 Sep 14; 6():32743. PubMed ID: 27624879
    [Abstract] [Full Text] [Related]

  • 14. NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128.
    Nanta R, Kumar D, Meeker D, Rodova M, Van Veldhuizen PJ, Shankar S, Srivastava RK.
    Oncogenesis; 2013 Apr 08; 2(4):e42. PubMed ID: 23567619
    [Abstract] [Full Text] [Related]

  • 15. Effects of baicalein on pancreatic cancer stem cells via modulation of sonic Hedgehog pathway.
    Song L, Chen X, Wang P, Gao S, Qu C, Liu L.
    Acta Biochim Biophys Sin (Shanghai); 2018 Jun 01; 50(6):586-596. PubMed ID: 29697746
    [Abstract] [Full Text] [Related]

  • 16. (‑)‑Epigallocatechin‑3‑gallate inhibits bladder cancer stem cells via suppression of sonic hedgehog pathway.
    Sun X, Song J, Li E, Geng H, Li Y, Yu D, Zhong C.
    Oncol Rep; 2019 Jul 01; 42(1):425-435. PubMed ID: 31180522
    [Abstract] [Full Text] [Related]

  • 17. Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms.
    Singh BN, Fu J, Srivastava RK, Shankar S.
    PLoS One; 2011 Jul 01; 6(11):e27306. PubMed ID: 22087285
    [Abstract] [Full Text] [Related]

  • 18. Epigallocathechin gallate, polyphenol present in green tea, inhibits stem-like characteristics and epithelial-mesenchymal transition in nasopharyngeal cancer cell lines.
    Lin CH, Shen YA, Hung PH, Yu YB, Chen YJ.
    BMC Complement Altern Med; 2012 Oct 30; 12():201. PubMed ID: 23110507
    [Abstract] [Full Text] [Related]

  • 19. Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial-Mesenchymal Transition: Enhanced Efficacy when Combined with Gemcitabine.
    Wei R, Penso NEC, Hackman RM, Wang Y, Mackenzie GG.
    Nutrients; 2019 Aug 09; 11(8):. PubMed ID: 31405071
    [Abstract] [Full Text] [Related]

  • 20. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
    Nalls D, Tang SN, Rodova M, Srivastava RK, Shankar S.
    PLoS One; 2011 Aug 09; 6(8):e24099. PubMed ID: 21909380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.